Validation of the Argentine version of the memory binding test (MBT) for early detection of mild cognitive impairment by Roman, Fabian et al.
Dement Neuropsychol 2016 September;10(3):217-226
217Roman et al.    Argentinian version of the Memory Binding Test 
Original Article
Validation of the Argentine version of 
the Memory Binding Test (MBT) for Early 
Detection of Mild Cognitive Impairment 
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ABSTRACT. Background: “Forgetfulness” is frequent in normal aging and characteristic of the early stages of dementia 
syndromes. The episodic memory test is central for detecting amnestic mild cognitive impairment (MCI). The Memory 
Binding Test (MBT) is a simple, easy and brief memory test to detect the early stage of episodic memory impairment. 
Objective: To validate the Argentine version of the MBT in a Latin American population and to estimate the diagnostic 
accuracy as a tool for early detection of MCI. Methods: 88 subjects (46 healthy controls and 42 patients with amnestic 
MCI) matched for age and educational level were evaluated by an extensive neuropsychological battery and the memory 
binding test. Results: A significantly better performance was detected in the control group; all MBT scales were 
predictive of MCI diagnosis (p<.01). The MBT showed high sensitivity (69%) and high specificity (88%), with a PPV of 
93% and a NPV of 55% for associative paired recall. A statistically significant difference (c2=14,164, p<.001) was 
obtained when comparing the area under the curve (AUC) of the MBT (0.88) and the MMSE (0.70). Conclusion: The 
Argentine version of the MBT correlated significantly with the MMSE and the memory battery and is a useful tool in the 
detection of MCI. The operating characteristics of the MBT are well suited, surpassing other tests commonly used for 
detecting MCI.
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VALIDAÇÃO DA VERSÃO ARGENTINA DO MEMORY BINDING TEST (MBT) PARA A DETECÇÃO PRECOCE DO TRANSTORNO 
COGNITIVO LEVE
RESUMO. “Esquecimento” é queixa frequente no envelhecimento normal e também ocorre nos primeiros estágios de 
síndromes demenciais. Testes de memória episódica são fundamentais para detectar comprometimento cognitivo 
amnéstico (CCL). O teste de Memória Associativa (Memory Binding Test-MBT) é um teste fácil e breve para detectar 
a fase inicial de perda de memória episódica. Objetivo: Validar a versão argentina do MBT e estimar a sua acurácia 
como instrumento diagnóstico para a detecção precoce do CCL. Métodos: 88 indivíduos (46 controles saudáveis  e 
42 pacientes com CCL amnéstico), emparelhados por idade e nível educacional, foram avaliados com extensa bateria 
neuropsicológica e o MBT. Resultados: Um desempenho significativamente melhor foi detectada no grupo controle; 
todas as escalas do MBT foram preditivas do diagnóstico de CCL (p<0,01). O MBT apresentou alta sensibilidade (69%) 
e alta especificidade (88%), com valor preditivo (VP) positivo de 93% e e VP negativo de 55% para a recordação dos 
itens associados (associative paired recall). Diferença estatisticamente significativa (c2=14,164, p<0,001) foi obtida 
quando foram comparadas as áreas sob as curvas (AUC) do MBT (0,88) e o Mini-Exame do Estado Mental (MEEM) (0,70). 
Conclusão: A versão argentina do MBT correlacionou-se significativamente com o MEEM e com a bateria de memória 
e é uma ferramenta útil na detecção de CCL. As características operacionais do MBT são bem adequadas, superando 
outros testes usualmente utilizados para a detecção de CCL.
Palavras-chave: memória episódica, doença de Alzheimer, detecção precoce, esquecimento, detecção, avaliação.
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INTRODUCTION 
“Forgetfulness” is very frequent in normal aging, but is also characteristic of the early stages of 
dementia syndromes. This situation has prompted neu-
roscientists for more than 40 years to try to differenti-
ate between age-related memory decline and memory 
impairment associated with neurodegenerative pro-
cesses. The low detection rate of Mild Cognitive Impair-
ment (MCI), the use of low-sensitivity screening tests, 
and the high prevalence of Alzheimer’s disease (AD), 
emphasize the need to develop simple, sensitive and spe-
cific instruments for early detection of MCI. There is now 
consensus that improving the early detection of Alzheim-
er’s disease, before dementia develops, is an urgent prior-
ity.1-3 This has led to several attempts at early detection, 
including AD biomarkers (neuroimaging and cerebro-
spinal fluid biomarkers) with the hope that early treat-
ment may be more effective. However, AD biomarkers 
are expensive, can be invasive, cannot be repeated easily 
and cannot be done in all patients. Dubois, Picard and 
Sarazin (2009) have pointed out that we need a simple 
screening test to select individuals for AD biomarkers.4
In the assessment of patients with dementia, the 
Mini-Mental State Examination (MMSE) is widely 
used as a screening instrument but lacks sensitivity for 
detecting MCI or early stages of dementia.5
We need an instrument for early detection of 
impaired memory that is sensitive, specific, brief, inex-
pensive, easy to administer and interpret, repeatable 
and effective for detection of early, pre-symptomatic 
memory impairment. Early detection of impairment 
when declining memory is still within the normal range 
will be useful to evaluate clinical trials of early treatment 
interventions for primary and secondary prevention, 
and to select individuals requiring neuroimaging and 
biomarker studies.
Memory Binding Test. The Memory Binding Test (MBT) is 
a screening test recently designed by Herman Buschke 
to detect impairment of memory early in the course of 
Alzheimer’s disease, other dementias, or other causes 
of memory impairment.6 Essential characteristics 
of the MBT include controlled learning, cued recall, 
encoding specificity to maximize recall and associative 
binding, and semantic interference.
Controlled Learning: tests of learning and memory 
generally use uncontrolled learning, in which partici-
pants are prompted to remember a list of items, which 
they can do however they want. Participants may use 
different strategies at different times, or different 
strategies from those used by other participants; these 
strategies are generally unknown to the evaluator. 
Uncontrolled learning limits the comparison of recall or 
memory performance across different testing sessions. 
Controlled learning is needed to ensure that poor recall 
is indeed due to impairment of memory rather than lack 
of attention or ineffective strategies. Controlled learning 
is also necessary for encoding specificity to maximize 
retrieval. A simple way of controlling learning is to pres-
ent the items to be remembered and to then ask the 
participant to identify each item when given the proper 
cue category. The category cues refer to when the items 
are already clearly associated: for example, everyone 
knows that an “Oak” (item) is a ‘tree’ (category). The 
advantages of controlled learning are to ensure appro-
priate care and equal treatment of all items, to induce 
deep semantic processing of all items, assess memory 
and learning through the items as memory units, induce 
all participants to do the same processing, show that 
the required processing was done, ensure that memory 
decline is due to memory impairment (not due to lack 
of attention or ineffective strategies), induce item bind-
ing to specific cue, and to provide the basis for encoding 
specificity to maximize the number of items recalled and 
the retrieval speed.
Cued Recall: Tulving (1974) has indicated that essen-
tially all recall is cued recall, suggesting that cued recall 
should be appropriate for assessing learning and mem-
ory.7,8 Tulving (1968) pointed out that the memory unit 
in free recall is not known.9 In free recall, the items are 
not learned independently, but are learned as part of 
a group containing several items that are remembered 
together.10,11 In cued recall, each item is learned and 
recalled independently, so the number of items retrieved 
by cued recall can provide an accurate estimate of learn-
ing and memory. Furthermore, when cued recall is coor-
dinated with controlled learning by using the same cues 
for learning and memory, the resulting encoding speci-
ficity maximizes recall and retrieval speed.
Maximum retrieval is not achieved by free recall.12 
Free recall is approximately half of cued recall. Free 
recall provides a measure of accessibility (what can be 
retrieved), and cued recall provides a measure of avail-
ability (what has been encoded and retained).13 Maxi-
mum retrieval is necessary to detect memory impair-
ment because “impairment” means maximum retrieval 
has decreased. For cued recall in the MBT, the cues are 
presented in the same order used during learning and 
the participant retrieves the item(s) associated with 
each cue.14-18
The procedures for cued recall and controlled learn-
ing are essentially the same. Controlled learning and 
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cued recall differ only in the source of the items. In 
controlled learning, the source of the items is a presen-
tation, while in cued recall, the items originate from 
memory, using the same cues in the controlled learning 
and the cued recall. The advantages of cued recall with 
the same cues used in learning are to ensure attention to 
and testing of all items, to assess memory and learning 
by items as legitimate memory units, to control order of 
recall (all participants recall all items in the same order 
on all tests, equalizing the interval between learning 
and recall of all items, obviating the need for interfer-
ence before recall, and preventing output order interfer-
ence), to achieve encoding specificity and to maximize 
the number of items recalled and retrieval speed.
Encoding specificity: the principle of “Encoding Speci-
ficity”19,20 is one of the most important concepts that we 
know about learning and memory.21 Encoding specific-
ity is the principle that we can only recall what we have 
learned, using appropriate recall cues that provide access 
to available information that was stored during learn-
ing. If we can recall only what has been retained using 
such appropriate cues, learning and memory must be 
coordinated to provide appropriate recall cues. Encoding 
specificity means that encoding and retrieval must be 
coordinated to achieve maximum learning and memory. 
In the MBT, learning and memory are coordinated using 
the same cues for learning and for recall.14,15
Binding: assessment of binding22,23 adds an estimate 
of associative learning24 to the MBT. Binding in the MBT 
is estimated by learning and recall of two items from 
the same category in association with a single shared 
category cue. Binding is shown in the paired recall con-
dition of the MBT by recall of both paired-items from 
each shared category in the 1st and 2nd lists (pairs); e.g., 
learning and recall of two items such as “Basketball 
and Rugby” are associated with the single category of 
“Sports” shared by both. Binding may be impaired in all 
older adults with dementia25 and may be affected in nor-
mal aging, which can serve as an early marker of mem-
ory impairment in the prodromal stage of Alzheimer’s 
disease.
Semantic interference: important studies by Loewen-
stein et al, 2007,26 using a version of the Fuld Object-
memory test27 (recall of objects withdrawn from a closed 
bag), developed the “Semantic Interference Test (SIT)” 
which shows that “vulnerability to semantic interfer-
ence” may identify “individuals with MCI likely to prog-
ress to dementia”.28-32 The MBT begins with learning 
and recall of two lists, so that proactive semantic inter-
ference can be assessed comparing recall of the second 
list with recall of the first list. Significantly lower recall 
of the second list shows proactive semantic interfer-
ence that may indicate early pre-symptomatic memory 
impairment.
The aim of the present study was to determine the 
reliability and validity of the Spanish version of the MBT 
in South America as a tool for early detection of MCI 
in a large sample at the Center for Aging and Memory 
Research of the Hospital Abel Zubizarreta of Buenos 
Aires City, Argentina.
METHODS
Design. This was a phase II cross-sectional study of 
elderly clinical patients attending the Center for Aging 
and Memory Research of the Hospital General Dr. Abel 
Zubizarreta, Government of Buenos Aires City, Argen-
tina, between 2013 and 2014. This study was approved 
by the Local Ethics Committee. After complete explana-
tion of the study to the participants, written informed 
consent was obtained. 
Study population. The general sample consisted of 88 
participants living in the city of Buenos Aires, Argen-
tina, comprising 2 groups, 46 healthy elderly (normal 
control, NC) group and 42 individuals with Mild cogni-
tive impairment (MCI) group. All participants were 
monolingual Rioplatense-Spanish speakers.
Participants were recruited from Center for Aging 
and Memory Research of the Hospital General Dr Abel 
Zubizarreta selected by convenience sampling of con-
secutive patients suspected of cognitive impairment. 
Case controls were caregivers and relatives of patients 
attending the center without relevant history of neuro-
logical, psychiatric or substance abuse problems. 
Procedure. For the evaluation of the population, a semi-
structured protocol was used (demographics, personal 
and family history, current medication, diagnosis, 
clinical and neurological examination), followed by an 
extensive neuropsychological battery including the 
Spanish version of the Mini-Mental State Examination 
(MMSE)4 for Buenos Aires,33 the Clock drawing test,34 
Signoret verbal memory battery,35 Trail Making Test,36 
Verbal Fluency,37 Spanish version of the Boston Naming 
Test,38 and the Digit Span forward and backward.39 For 
the study of depressive features, the self-administered 
scale of depression by Beck et al., 1961 was applied.40 
Patients were staged by a neurologist according to the 
Clinical Dementia Rating (CDR).41
Based on the above, for the final diagnosis of 
patients the following MCI criteria42 were used: a) 
memory complaint corroborated by an informant; b) 
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memory impairment (score on the Signoret memory 
battery below 1.5 SD – age and education-adjusted); c) 
normal global cognitive function; d) normal activities of 
daily living; and e) absence of dementia. 
Memory Binding Test (MBT). The Memory Binding Test 
(MBT) is a simple test in which the participant must 
learn and remember two lists of words by controlled 
learning (CL) and cued recall (CR). The MBT consists of 
two lists each containing 16 words belonging to one of 
16 different semantic categories. The categories are the 
same in both lists, but the words of each category in the 
two lists differ. For example, for “Tree” (category cue) 
the item in list 1 may be “Oak” whereas the item in list 2 
might be “Eucalyptus”. These categories are used in the 
same order for the controlled learning and cued recall 
in both lists. Five seconds are allowed for each response 
in controlled learning and cued recall. After cued 
recall of list 1, list 2 is learned immediately, without 
delay or interference, as more than six items between 
learning and recall prevents retrieval from immediate 
memory.43 After recall of list 2, the same category cues 
are presented again, and the participant is asked to 
recall both paired-items from both lists for each cate-
gory cue (in any order). This paired-recall condition 
provides an estimate of binding of two items to the 
same category cue, evidenced by the number of pairs 
recalled from the two lists. The participant is given 10 
seconds to recall the two items of both lists associated 
with each category. After paired recall, the participant 
is asked to perform “free recall” of the 32 items of both 
lists (in any order). Free recall can be continued until 
there is no response for 15 seconds.
Scoring of MBT. Since each item (word) is processed 
independently in controlled learning and cued recall, 
each item is a memory unit in learning and recall, so 
that the number of items recalled in the MBT should 
provide more accurate estimates of learning and 
retrieval, unlike free recall where the items are learned 
in chunks10,11 and the memory unit is unknown.9
Basic results on the MBT are: [1] Cue Recall List 1 
(CRL1): the number of items recalled from list 1 (range 
0-16); [2] Cue Recall List 2 (CRL2): the number of items 
recalled from list 2 (range 0-16); [3] Cue Recall Both List 
1 (CRBL1): the number of items in list 1 recalled from 
Cue Recall Both Lists (range 0-16); [4] Cue Recall Both 
List 2 (CRBL 2): the number of items in list 2 recalled 
from Cue Recall Both Lists (range 0-16); [5] Total Paired 
Recall (TPR): the number of pairs remembered with 
category cue (range 0-16); [6] Percentage Paired Recall 
(PPR): paired-items as a percentage of pairs recalled in 
paired recall; [7] Free Recall (FR): the number of items 
recalled by Free Recall at 30, 60, 90, and 120 seconds 
(range 0-32 ).
Intrusions and repetitions are recorded, but not 
included in the general results, since intrusions repre-
sent guesses and may provide the basis for correction 
of guessing. 
The total paired recall condition (TPR) is a critical 
measure that estimates associative binding. A score 
that incorporates item recall and paired recall can be 
obtained by adding one point for each item recalled in 
the paired recall condition plus one point for each pair 
recalled.
Tounsi et al (1999)17 have provided an important 
measure of “sensitivity to semantic cuing” replicated by 
Sarazin et al. (2007),18 which is essentially an estimate 
of the proportion of cues that are successful. 
Spanish translation and transcultural adaptation of the MBT. 
Although there is a Spanish version of the MBT for 
Spain44-46 and another for Colombia,47 some words are 
infrequent in Argentina (zumo, laton, taburete, alicates, 
ensaimada, aspirador, colgantes, vitrina, cipres, among 
others). These could have affected the Encoding Speci-
ficity and Binding, two important aspects of the MBT. 
Therefore, it was decided to produce an Argentine 
version of the MBT with words that avoid difficulty in 
the application of the test in the group under study.
Spanish translation and adaptation of the MBT was 
performed in two stages. The first stage corresponded 
to the initial translation and adaptation to the Span-
ish language, this was done by a first team formed by a 
neuropsychologist, neurologist, and a psychiatrist (all 
three were bilingual (Spanish natives)). The transla-
tion from English into Spanish of all lists of words and 
their corresponding categories was performed, then the 
translation from Spanish into English was performed, 
and if the meaning of the words in both languages  was 
the same the word was included in the list of the Span-
ish version.
At a second stage, the translated and adapted ver-
sion was presented to a group of 10 professionals with 
expertise in clinical and memory problems research. 
The group comprised 4 neurologists, 2 psychiatrists, 
and 4 neuropsychologists. This enabled a consensus to 
be reached on the categories and the items of each list 
of words used. The group was consulted on the words 
(translated items) along with their relevance and fre-
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quency of use in the study population. At this stage, 
the categories were adapted to similar terms used in 
the region, for example in the original test the category 
“state” was included, whereas in the Argentinian version 
“province” was used. The items in the categories were 
also adapted, such as “male name”, “Sports”, and com-
mon names used in the country.
Data analysis. Demographic variables (age and educa-
tion), neuropsychological battery scores, MMSE, CDT 
and MBT scores were compared by one-way analyses of 
variance (ANOVA). The Chi-square test was employed 
for categorical data (gender). Neuropsychological 
tests were scored using the raw scores. To assess the 
frequency and extent of clinically relevant neuropsy-
chological deficits, each test score of the patient group 
was compared with the respective norm group (control 
group). Measurements in patients who scored at least 
1.5 SD below average compared to age and education-
matched controls were considered abnormal. ANOVA 
were performed to assess the effect of age, sex, and their 
interaction on different fluency measures, performance 
over time, and the use of clustering and switching strat-
egies. Partial Eta squared was used to determine the 
effect size of multivariate and univariate Fs. Compli-
ance with homogeneity of variance assumption was 
confirmed before analysis. The degree of association 
between variables was calculated using Pearson’s corre-
lation coefficient. Finally, stepwise regression analyses 
were used to determine the relative contributions of 
cognitive strategies to explaining the variance in VF 
measures. The diagnostic accuracy of the scores was 
assessed by establishing Sensitivity (Sn) and Speci-
ficity (Sp) for the optimal cut-offs. Receiver operating 
characteristic (ROC) curve analysis was performed 
to evaluate discriminative power between different 
screening tests. Area under the curve (AUC) was used as 
a measure of overall ROC curve performance (95% CI). 
Data processing and statistical analysis were performed 
using the Statistical Package for the Social Sciences 
(SPSS) version 15.0, and a statistical significance level 
below .05 was set.
RESULTS
Demographic data. 42 patients with MCI and 46 normal 
control subjects matched for age, education and sex 
were assessed by an extensive neuropsychological 
battery (Table 1). A significantly better performance on 
cognitive assessment in the control group was expected. 
To confirm this, the distributions of the dependent 
variables were examined, verifying that most of them 
did not follow a normal distribution, therefore the 
Mann-Whitney non-parametric U-test was calculated. 
All tests showed statistically significant differences, 
thereby confirming that the controls performed better. 
Validation of the MBT. The convergent and discrimina-
tive validity between the scales of the MBT and the 
Signoret memory battery and the MMSE was assessed 
by Pearson correlations, showing a statistically signifi-
cant value for all subscales of the MBT (p<0.001).
Operational characteristic of MBT. The operational char-
acteristics of the MBT were studied. To assess sensi-
tivity and specificity, the MCI diagnosis was based 
on the cognitive performance of the tests (z-score 
of –1.5 obtained). To assess the z-score, the means 
and standard deviations were obtained in the control 
group, based on age and years of education. The posi-
tive predictive value and negative predictive value were 
obtained in each case (Table 2).
Discriminative power of MBT. To evaluate the discrimina-
tive power of the test, we calculated logistic regressions 
to verify the predictive ability of the scales for the diag-
nosis of MCI (see Table 2). All MBT scales were predic-
tive of MCI diagnosis (p<0.01). They had adequate 
sensitivity and specificity above the cognitive tests 
used in this study. The ROC curve of all scales of MBT 
was calculated. 
Operational characteristic of MBT vs MMSE. Comparison 
of the operational characteristics of the MBT vs the 
MMSE and ROC curves was carried out. Sensitivity, 
specificity, positive predictive value and negative 
predictive value of the MBT and MMSE were also 
compared. The area under the curve (AUC) for the MBT 
was 0.88 (95% CI: 0.84-0.93) and for the MMSE was 
0.70 (95% CI 0.62 to 0.78). The test of Hanley and 
McNeil was used to compare the areas under the curve 
for both tests revealing a statistically significant differ-
ence (c2=14,164, p<.001). Therefore, the diagnostic 
utility of the MBT was significantly higher than that of 
the MMSE.
Performance on MBT by age and education in the normal 
healthy population. MBT standardization was performed 
by age and education in the normal healthy popula-
tion (a z-score cut-off of –1.5 was used for all tests 
(Table 3)). 
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Table 1. Demographic data and neuropsychological battery.
Controls MCI Mann-Whitney/c2
M SD M SD U p-value
Nº 46 42
Age (Years) 67.5 8.3 65.3 5.4 781.500 ns
Education (Years) 11.5 4.1 10.5 1.2 838.000 ns
MMSE 28.3 4.1 27.6 1.3 696.000 <0.05
CDT 6.6 0.8 6.1 1.4 695.000 <0.05
Neuropsychological Assessment
Signoret Memory Battery Verbal Serial Learning 8.5 1.2 6.9 1.5 441.500 <0.001
Delayed Free Recall 8.1 1.2 5.3 2.2 301.500 <0.001
Recognition 11.7 0.6 10.2 1.9 347.000 <0.001
Language Boston naming test 50.6 4.3 44.4 8.4 442.000 <0.001
Category VFT 16.2 3.6 15.6 4.6 815.000 ns
Letter VFT 14.4 3.1 12.5 3.7 641.000 <0.05
Attention Forward Digit Span 5.3 1.0 5.1 1.0 820.500 ns
TMT- A (seconds) 51.3 15.5 61.8 21.3 658.000 <0.05
Visuo-spatial Pentagons MMSE 0.8 0.3 0.8 0.4 861.000 ns
Executive TMT B (seconds) 128.8 93.4 191.2 130.4 583.000 <0.005
Memory Binding Test
Cue Recall List 1 15.2 1.1 13.9 2.4 628.000 <0.005
Cue Recall List 2 13.7 1.5 10.7 2.9 377.000 <0.001
Both Cue Recall 1st list 14.5 1.5 12.5 2.8 509.000 <0.001
Both Cue Recall 2nd list 14.2 1.2 11.3 2.8 336.000 <0.001
Total Paired Recall 13.0 1.7 9.1 3.5 319.000 <0.001
Percentage Paired Recall 0.90 0.06 0.72 0.16 321.500 <0.001
Free recall at 30” 11.7 2.9 9.0 3.9 563.500 <0.005
Free recall at 60” 15.5 3.3 11.8 4.5 530.000 <0.001
Free recall at 90” 18.0 3.7 13.3 4.9 471.500 <0.001
Final Free recall at 120” 19.8 4.2 14.3 5.2 424.500 <0.001
Intrusions in 2nd list 1.26 1.30 2.71 2.29 588.000 <0.005
Intrusions in Both lists 0.52 0.86 1.86 2.69 583.000 <0.005
Intrusion in Free recall 0.35 0.60 0.69 0.97 787.000 ns
Repetition in Free recall 1.04 1.63 1.07 1.04 899.000 ns
Values shown represent mean (M) and standard deviation (SD) results except for sample size and sex. Neuropsychological tests scores are represented as raw scores.  MCI, mild cognitive impair-
ment; MMSE, Mini-Mental State Examination Test; CDT, Clock Drawing Test; VFT, verbal fluency test; Forward Digit Span Subtest of WMS III; TMT, trail making test A and B. Comparisons simultane-
ously made among all groups using ANOVA test for all participant features except sex (c2 test).
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Table 2. MBT: Operational characteristic and discriminative power.
 Discriminative Power  Operational Characteristic
p-value OR AUC Sn Sp PPV NPV
Total Paired Recall <.001 .527 .889 0.69 0.88 0.93 0.55
Percentage Paired Recall <.001 .000 .888 0.69 0.90 0.94 0.56
Weighted Recall <.001 .745 .886 0.66 0.90 0.94 0.53
Final Free Recall 120” <.001 .712 .857 0.49 0.92 0.93 0.44
Total Intrusions 2nd List <.001 1.92 .781 0.55 0.90 0.93 0.47
Total Intrusions both Lists <.001 2.34 .748 0.40 0.88 0.89 0.39
nº=175 (Controls 53; MCI 122); Discriminative power by logistic regressions; AUC: area under the ROC curve; Sn: sensitivity; Sp: specificity; PPV: positive predictive value; NPP: negative predictive value.
Table 3. MBT: Norms in normal healthy subjects.
Normal Healthy Population
65 years or less 66 years or more
12 years of  
education or less
13 years of  
education or more
12 years of  
education or less
13 years of  
education or more
Controlled Learning List 1 14.92 (1.37) 15.70 (0.67) 15.27 (1.07) 15.33 (1.00)
Controlled Learning List 2 13.42 (1.44) 14.20 (1.87) 13.73 (1.57) 14.11 (1.45)
Cue Recall List 1 14.58 (1.56) 15.50 (0.52) 14.27 (1.69) 14.67 (1.65)
Cue Recall List 2 14.25 (1.13) 14.30 (1.33) 14.41 (1.36) 14.44 (1.13)
Total Paired Recall 13.17 (1.74) 13.90 (1.52) 13.09 (1.92) 13.33 (2.00)
 Percentage Paired Recall 0.90 (0.05) 0.92 (0.06) 0.90 (0.07) 0.90 (0.07)
 Free Recall at 30” 10.83 (2.79) 15.30 (3.12) 11.59 (2.80) 11.89 (2.31)
 Free Recall at 60” 14.25 (2.92) 20.70 (3.40) 15.45 (3.39) 15.56 (2.50)
 Free Recall at 90” 16.42 (3.80) 22.30 (2.75) 18.09 3.32) 18.11 (4.28)
 Final Free Recall at 120” 18.17 (3.61) 23.60 (2.50) 19.73 (3.94) 20.22 (5.60)
 Intrusions 2nd List 1.50 (1.08) 1.50 (1.78) 1.14 (1.20) 0.78 (1.30)
 Intrusions both Lists 0.67 (0.98) 0.30 (0.67) 0.55 0.85) 0.22 (0.66)
 Intrusions Free Recall 0.50 (0.67) 0.00 (0.00) 0.36 (0.58) 0.33 (0.70)
 Repetitions Free Recall 1 (1.41) 0.60 (0.84) 1.41 (1.35)  1.11 (2.66)
 nº=Normal Healthy Population 53. Values shown represent mean (M) and standard deviation (SD).
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DISCUSSION
The aim of this investigation was to evaluate the perfor-
mance of the Spanish version of the MBT as a screening 
instrument in a population of MCI and control subjects 
in Buenos Aires, Argentina. Screening is a “first step” 
in detecting Alzheimer’s disease, and therefore, an 
important public health and clinical initiative.48 Essen-
tial features of an effective memory test for screening 
pre-dementia memory impairment are controlled 
learning, cued recall, encoding specificity and associa-
tive binding. All memory tests are not equal.49 Many 
memory tests are used to detect impairment, but note, 
when memory impairment is severe enough, almost 
any memory test can detect impairment. Most memory 
tests do not use controlled learning; other tests do not 
induce encoding specificity to maximize retrieval. Many 
memory tests are based on free recall, which does not 
maximize retrieval, and others are limited to learning a 
list of items and do not include binding. Most memory 
tests are based on comparisons of performance against 
control subjects matched for age. Consequently, impair-
ment can be detected only when it is severe and there-
fore late, precluding the early detection of memory 
impairment in the pre-symptomatic stage. 
The MBT is designed to improve the detection of 
truly early memory impairment, when declining mem-
ory is still within the normal range, by overcoming cer-
tain limitations of the Buschke Free and Cue Selective 
Reminding test (FCSRT).15
The MBT consists of two lists of words. By using con-
trolled learning and cued recall, the encoding specificity 
is created by the associative union of the words to cued 
category; detecting memory problems through decrease 
in maximum retrieval. Cued recall provides memory 
units that can be used to estimate learning and memory 
and maximizes recall which is essential for detection of 
memory impairment. Impaired associative binding, evi-
denced by the low number of pairs remembered through 
unique cue categories, may provide a marker of early 
memory impairment in older adults with Alzheimer’s 
disease or other dementias,50 and in some older adults 
without apparent memory impairment tests according 
to standard tests. The MBT associated binding provides 
a marker of early memory impairment. The MBT is brief, 
about 6 minutes for controlled learning and cued recall 
of list 1 and list 2, and recall of paired-items. The MBT 
is easily administered, and can be repeated. It is inex-
pensive and very well accepted by the elderly, as they 
feel more comfortable with cued recall than free recall. 
The MBT can serve as a basis to select individuals for 
AD biomarkers.51,52
In the present study, the control group and the MCI 
group were compared using the scales of the MBT and 
the Signoret memory battery as well as the MMSE, 
revealing significantly better performance in the control 
group in statistical terms.
It was observed that all the scales of the MBT were 
predictive for amnesic MCI diagnosis with adequate sen-
sitivity and specificity above the cognitive tests used in 
this study.
The MBT had better sensitivity/specificity than the 
MMSE. The MMSE was unable to detect MCI. In addi-
tion, the MBT is a highly sensitive and specific screening 
test for detecting amnesic MCI. 
A statistically significant difference was apparent 
when comparing the AUC of the MBT to that of the 
MMSE, showing the diagnostic utility of the MBT.
A limitation of the present work is that MCI cases 
were clinically defined but no biomarkers were used to 
define whether these patients had Alzheimer’s disease. 
The MBT can serve as a basis to select individuals for 
biomarkers.51,52
The new criteria for Alzheimer’s disease proposed 
by Dubois et al.2,4 suggested that the diagnosis of 
Alzheimer’s disease should be based on impairment of 
hippocampal type memory,18 as disclosed by memory 
tests that include controlled learning and cued recall, 
confirmed by AD biomarkers. 
The MBT aims to improve early detection of memory 
disorders and decline when memory is still within the 
normal range, while overcoming some limitations of 
other tests. These limitations include: a) memory units, 
b) associative binding, c) maximum retrieval, and d) 
















Figure 1. Comparison ROC Curve – MBT (N° Paired recall) vs MMSE.
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In conclusion, early detection in the pre-dementia 
stage of Alzheimer’s disease and other dementias is 
needed not only for clinical application but also as an 
instrument to assess clinical trials, evaluate the effec-
tiveness of early interventions, and to select individuals 
for AD biomarker studies.
Since forgetfulness is often the earliest and most 
prominent feature in Alzheimer’s disease, a test to 
detect memory impairment should be brief, easy to 
repeat and low cost to allow the detection of memory 
impairment at the pre-symptomatic stage.
The MBT is a useful tool in the detection of MCI, 
constituting a simple, easily administered test that 
places low burden on the patient. Statistical analyzes 
indicated that the operating characteristics of the MBT, 
as well as its sensitivity, specificity, positive predictive 
value and negative predictive value are well suited, sur-
passing other tests commonly used for detecting MCI.
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